VELLANKI AVANISH (President and CEO) purchased 1.0% of their position (25K shares) of RAIN ONCOLOGY INC. on the open market
Open‑market purchase worth $57.3K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/2/2022ACC: 0000899243-22-020666
DirectorOfficer· President and CEO
Since Apr 2021
+25K
Net shares
Net buyer
$57.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
25K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25K
Price / share
$2.29
Trade value
$57.25K
% of position
1.0%
6/1/2022
2.45M→2.47M
Total
Net shares
+25K
Net value
$57.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2022 | P · Purchase | +25K | $2.29 | $57.25K | 1.0% | 2.45M | 2.47M |
| Total | +25K | $57.25K | ||||||
Derivative Transactions0
No derivative transactions reported